D&D Pharmatech

company

About

D&D Pharmatech is a Health care Company.

  • 11 - 50

Details

Last Funding Type
Series C
Last Funding Money Raised
$51M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

D&D Pharmatech is a operator of a holding company created to fund the development of therapeutic medicines through disease-specific subsidiary companies founded and guided by top-tier medical research faculty. The company's product pipeline focuses on a range of indications including neurodegenerative, metabolic and fibrotic diseases, providing the opportunity to accelerate the translation of cutting-edge research into lifesaving therapeutic products for patients.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$87M
D&D Pharmatech has raised a total of $87M in funding over 2 rounds. Their latest funding was raised on Oct 19, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 19, 2021 Series C $51M 1 Detail
Jan 1, 2018 Series A $36M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
D&D Pharmatech is funded by 2 investors. Korea Investment Securities and Geon Investment are the most recent investors.
Investor Name Lead Investor Funding Round
Korea Investment Securities Series C
Geon Investment Series A